HIV remains a persistent public health challenge in the United States. While infection rates have steadily declined over the ...

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic ...

A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

Headquartered in Humacao, Puerto Rico, Aspire Biopharma has developed a disruptive technology through a novel soluble formulation which addresses emergencies, drug efficacy, dosage management, and ...

American depositary receipts of Argenx rose after the company received approval from the Food and Drug Administration for a new delivery method of its treatment for some patients with certain ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...

Satio announced today that it completed a Small Business Innovation Research (SBIR) contract for its intradermal drug ...

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...

Integrating the Arabic language into the Company's portable Drug Screening Reader will improve accessibility and usability for Arabic-speaking organizations in the Middle East. With the workplace drug ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit ...